SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Two insiders at Oruka Therapeutics, General Counsel Paul Quinlan and…

Oruka Therapeutics, Inc. · CLUSTER filed Jun 15, 2026 at 18:50 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 15, 2026 at 18:50 ET

Two insiders at Oruka Therapeutics, General Counsel Paul Quinlan and Director Carl Dambkowski, sold a combined $933K in open-market transactions over four days. While the insider cluster is selling, the total value is only ~0.02% of the company's $4.2B market cap, making the signal economically trivial. The cross-filing actuarial verdicts strongly amplify the cluster-earnings-context and cluster-insider-trades pair, but neither earnings nor other material cross-filings are present in the actual context provided, so the amplifiers fire without a substantive base event.

  • Cluster comprises 2 insiders selling over 4-day window (June 11–15, 2026)
  • Total open-market sales: $933K, roughly 0.02% of ORKA's $4.2B market cap
  • Director Dambkowski sold 35K shares combined for ~$2.45M; General Counsel Quinlan sold 733 shares for $51K
  • No earnings, offering, or material corporate event cross-filings present to provide informational context

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access